Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...
"Patients who undergo surgery and end up developing post-surgical neuropathic pain, may experience debilitating complications that often are ... AV001 is a randomized, double-blind 42 week trial ...
The Phase III trial AV001 aims to evaluate QUTENZA in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical procedures ...
Key Laboratory of Spine and Spinal Cord Injury Repair and Regeneration of Ministry of Education, Orthopaedic Department of Tongji Hospital, School of Medicine, School of Life Sciences and Technology, ...
or a nerve-related headache. Most of the conditions that lead to pain behind the ear aren't serious. Rarely, a tumor in or near the ear may be cancerous. Or, an untreated ear infection can lead to ...